Temporal characteristics of the protective effect of aminoguanidine on cerebral ischemic damage

Brain Research

Volumn 802, Issue 1-2, 1998, Pages 104-110

  Zhang, Fangyi ^a   Iadecola, Costantino ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Inducible nitric oxide synthase; Middle cerebral artery; Nitric oxide; Rat; Stroke

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; BRAIN SIZE; CHRONOLOGY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HEMATOCRIT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PH; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; STROKE;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY TEMPERATURE; BRAIN ISCHEMIA; CEREBRAL INFARCTION; GASES; GUANIDINES; HEMATOCRIT; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED SHR; RECTUM; TIME FACTORS;

EID: 0345131715     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00557-5     Document Type: Article

References (27)

1. M. Anwar, O. Costa, A.K. Shina, H.R. Weiss, Middle cerebral artery occlusion increases cerebral capillary permeability, Neurol. Res. 15 (1993) 232-236.
2. A.E. Baird, A. Benfield, G. Schlaug, B. Siewert, K.-O. Lövblad, R.R. Edelman, S. Warach, Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging, Ann. Neurol. 41 (1997) 581-589.
3. J.-C. Baron, R. von Kummer, G.J. del Zoppo, Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window, Stroke 26 (1995) 2219-2221.
4. S. Baylin, Z. Horakova, M.A. Beaven, Increase in food consumption and growth after treatment with aminoguanidine, Experientia 31 (1975) 562-564.
5. M.A. Beaven, J.W. Gordon, S. Jacobsen, W.B. Severs, A specific and sensitive assay for aminoguanidine: its application to a study of the disposition of aminoguanidine in animal tissues, J. Pharmacol. Exp. Ther. 165 (1969) 14-22.
6. M. Brownlee, H. Vlassara, A. Kooney, P. Ulrich, A. Cerami, Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking, Science 232 (1986) 1629-1632.
7. K.M. Cockroft, M.I. Meistrell, G.A. Zimmerman, D. Risucci, O. Bloom, A. Cerami, K.J. Tracey, Cerebroprotective effects of aminoguanidine in a rodent model of stroke, Stroke 27 (1996) 1393-1398.
8. M.O. Dereski, M. Chopp, R.A. Knight, L.C. Rodolosi, J.H. Garcia, The heterogeneous temporal evolution of focal ischemic neuronal damage in the rat, Acta Neuropathol. 85 (1993) 327-333.
9. J.H. Garcia, Y. Yoshida, H. Chen, Y. Li, Z.G. Zhang, J. Lian, S. Chen, M. Chopp, Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat, Am. J. Pathol. 142 (1993) 623-635.
10. M.D. Ginsberg, M. Globus, R. Busto, W.D. Dietrich, The potential of combination pharmacotherapy in cerebral ischemia, in: J. Krieglstein, H. Oberpichler (Ed.), Pharmacology of Cerebral Ischemia, Wissenschaftliche Verlagsgesellschaft, Stuttgard, 1990, pp. 499-510.
11. W.-D. Heiss, M. Huber, G.R. Fink, K. Herloz, U. Pietrzyk, R. Wagner, K. Weinhard, Progressive derangement of peri-infarct viable tissue in ischemic stroke, J. Cereb. Blood Flow Metab. 12 (1992) 193-203.
12. K.-A. Hossmann, Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised, Brain Pathology 4 (1994) 23-36.
13. Z. Huang, P.L. Huang, J. Ma, W. Meng, C. Ayata, M.C. Fishman, M.A. Moskowitz, Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine, J. Cereb. Blood Flow Metab. 16 (1996) 981-987.
14. C. Iadecola, X. Xu, F. Zhang, E.E. El-Fakahany, M.E. Ross, Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia, J. Cereb. Blood Flow Metab. 14 (1995) 52-59.
15. C. Iadecola, F. Zhang, R. Casey, M. Nagayama, M.E. Ross, Delayed reduction in ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene, J. Neurosci. 17 (1997) 9157-9164.
16. C. Iadecola, F. Zhang, X. Xu, Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage, Am. J. Physiol. 268 (1995) R286-R292.
17. C. Iadecola, F. Zhang, X. Xu, R. Casey, M.E. Ross, Inducible nitric oxide synthase gene expression in brain following cerebral ischemia, J. Cereb. Blood Flow Metab. 15 (1995) 378-384.
18. T.-N. Lin, Y.Y. He, G. Wu, M. Khan, C.Y. Hsu, Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats, Stroke 24 (1993) 117-121.
19. G. Marchal, V. Beaudouin, P. Rioux, V. de la Sayette, F. Le Doze, F. Viader, J.-M. Derlon, J.-C. Baron, Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke, Stroke 27 (1996) 599-606.
20. M. Nagayama, F. Zhang, C. Iadecola, Delayed treatment with aminoguanidine reduces focal cerebral ischemic damage and enhances neurological recovery in rats, J. Cereb. Blood Flow Metab. (1998) in press.
21. C. Nathan, Inducible nitric oxide synthase: what difference does it make?, J. Clin. Invest. 100 (1997) 2417-2423.
22. W. Paschen, M. Cleef, G. Röhn, M. Müller, A.E.I. Pajunen, Ischemia-induced disturbances of polyamine synthesis, Progress in Brain Research 96 (1993) 147-160.
23. A. Sessa, A. Perin, Diamine oxidase in relation to diamine and polyamine metabolism, Agents Actions 43 (1994) 69-77.
24. F. Zhang, C. Iadecola, Stimulation of the fastigial nucleus enhances EEG recovery and reduces tissue damage after focal cerebral ischemia, J. Cereb. Blood Flow Metab. 12 (1992) 962-970.
25. F. Zhang, C. Iadecola, Infarct measurement methodology, J. Cereb. Blood Flow Metab. 14 (1994) 697-698.
26. G.A. Zimmerman, O. Bloom, M.I. Meistrell, D. Ford, M. Bianchi, K.J. Tracey, Aminoguanidine attenuates focal cerebral ischemia, Surg. Forum 45 (1994) 600-603.
27. G.A. Zimmerman, M.I. Meistrell, O. Bloom, K.M. Cockroft, M. Bianchi, D. Risucci, J. Broome, P. Farmer, A. Cerami, H. Vlassara, K.J. Tracey, Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine, Proc. Natl. Acad. Sci. USA 92 (1995) 3744-3748.